|
|
Volumn 18, Issue 3, 2012, Pages 327-
|
|
Trial designs for vaccines adapt to the times
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BCG VACCINE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
VACCINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CHILD;
CLINICAL PROTOCOL;
CLINICAL TRIAL (TOPIC);
COST EFFECTIVENESS ANALYSIS;
DRUG INDUSTRY;
DRUG SAFETY;
HUMAN;
INFANT;
INFECTION;
LUNG TUBERCULOSIS;
MAJOR CLINICAL STUDY;
NOTE;
PHASE 1 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
TREATMENT RESPONSE;
TUBERCULOSIS;
VACCINATION;
AIDS VACCINES;
CLINICAL TRIALS AS TOPIC;
DEVELOPING COUNTRIES;
HIV INFECTIONS;
HUMANS;
NEGLECTED DISEASES;
TUBERCULOSIS;
TUBERCULOSIS VACCINES;
VACCINES;
|
|
EID: 84857942017
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0312-327 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
